A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients.

scientific article

A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/1759091415609613
P8608Fatcat IDrelease_sd2kjvcz5vaotg23jhhur7xzgq
P932PMC publication ID4710131
P698PubMed publication ID26489686
P5875ResearchGate publication ID283337471

P50authorCharles L WhiteQ60638965
E. Sally WardQ75346560
Jacqueline R RivasQ86532028
P2093author name stringWilliam Robinson
Min Li
Ann J Ligocki
Elliot M Frohman
Ding Chen
Edgar Meinl
Ann M Stowe
Nancy L Monson
William H Rounds
Benjamin M Greenberg
Donna Graves
Lauren Lahey
Melania Spadaro
Alyssa A Guzman
Paul M Henson
P2860cites workThe onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodiesQ24316787
Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brainQ24602799
Role of T cell-glial cell interactions in creating and amplifying central nervous system inflammation and multiple sclerosis disease symptomsQ26795528
Multiple sclerosis-a quiet revolutionQ26826930
B-cell depletion with rituximab in relapsing-remitting multiple sclerosisQ28268626
Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodiesQ28282500
Multiple sclerosisQ28299151
The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementiaQ28513858
Pore membrane and/or filament interacting like protein 1 (POMFIL1) is predominantly expressed in the nervous system and encodes different protein isoformsQ28587441
Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFPQ29547505
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelinationQ29614990
Axonal transection in the lesions of multiple sclerosisQ29615585
Gray matter damage in multiple sclerosis: Impact on clinical symptomsQ30979785
Specificity of recombinant antibodies generated from multiple sclerosis cerebrospinal fluid probed with a random peptide libraryQ33230101
Nerve blocks for cutaneous surgery on the footQ33560738
Cortical lesions in multiple sclerosisQ33631075
Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluidQ33745475
Intrathecally synthesized IgG in multiple sclerosis cerebrospinal fluid recognizes identical epitopes over timeQ34073320
A unique antibody gene signature is prevalent in the central nervous system of patients with multiple sclerosisQ34117793
The antibody genetics of multiple sclerosis: comparing next-generation sequencing to sanger sequencingQ34193087
Memory B cells from a subset of treatment‐naïve relapsing‐remitting multiple sclerosis patients elicit CD4+ T‐cell proliferation and IFN‐γ production in response to myelin basic protein and myelin oligodendrocyte glycoproteinQ34773444
Expansion of CD27high plasmablasts in transverse myelitis patients that utilize VH4 and JH6 genes and undergo extensive somatic hypermutation.Q35077861
Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis PatientsQ35744057
A Longitudinal Study of Disability, Cognition and Gray Matter Atrophy in Early Multiple Sclerosis Patients According to Evidence of Disease ActivityQ35747637
A nuclear factor containing the leucine-rich repeats expressed in murine cerebellar neurons.Q35806036
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosisQ35986699
Cerebrospinal fluid B cells from multiple sclerosis patients are subject to normal germinal center selection.Q36082102
MSPrecise: A molecular diagnostic test for multiple sclerosis using next generation sequencingQ36433030
Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminalQ36455215
Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloningQ36459907
The neurobiology of multiple sclerosis: genes, inflammation, and neurodegenerationQ36610350
Hel-N1: an autoimmune RNA-binding protein with specificity for 3' uridylate-rich untranslated regions of growth factor mRNAsQ36686295
Specific peripheral B cell tolerance defects in patients with multiple sclerosisQ36890946
The comparative biology of neuromelanin and lipofuscin in the human brainQ37085791
Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MSQ37258223
Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.Q37304222
Polyreactive autoantibodies in systemic lupus erythematosus have pathogenic potentialQ37439187
Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis.Q37445439
Spinal cord gray matter atrophy correlates with multiple sclerosis disabilityQ37651386
Autoantibodies to intracellular antigens: generation and pathogenetic role.Q37852410
Antibody-independent B cell effector functions in relapsing remitting multiple sclerosis: clues to increased inflammatory and reduced regulatory B cell capacity.Q37995305
Immunology of relapse and remission in multiple sclerosisQ38179507
B cells in MS and NMO: pathogenesis and therapyQ38212081
Targets of the humoral autoimmune response in multiple sclerosisQ38238409
Significance of gray matter brain lesions in multiple sclerosis and neuromyelitis opticaQ38529196
Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseasesQ39353775
Transplanted neural precursors enhance host brain-derived myelin regenerationQ39762323
Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1.Q39786593
The neuronal component of gray matter damage in multiple sclerosis: A [(11) C]flumazenil positron emission tomography studyQ40622624
Periventricular lesions correlate with cortical thinning in multiple sclerosisQ40825942
Repetitive hypoxia extends endogenous neurovascular protection for strokeQ41991619
A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis.Q42847184
The brain-specific Neural Zinc Finger transcription factor 2b (NZF-2b/7ZFMyt1) causes suppression of cocaine-induced locomotor activityQ43270146
Serum and cerebrospinal fluid heavy neurofilaments and antibodies against them in early multiple sclerosis.Q44403860
Arginines in the CDR of anti-dsDNA autoantibodies facilitate cell internalization via electrostatic interactionsQ45399598
Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model.Q45902843
A nucleic acid-hydrolyzing antibody penetrates into cells via caveolae-mediated endocytosis, localizes in the cytosol and exhibits cytotoxicityQ47994013
Intrathecal activation of the complement system and disability in multiple sclerosisQ47995950
Mouse-Musashi-1, a neural RNA-binding protein highly enriched in the mammalian CNS stem cellQ48063176
Subpial demyelination in the cerebral cortex of multiple sclerosis patientsQ48233815
Evidence for progressive gray matter loss in patients with relapsing-remitting MS.Q48735996
Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosisQ48949365
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosisQ48949792
Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid.Q54759503
Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitisQ57767625
Gray matter atrophy is related to long-term disability in multiple sclerosisQ61861932
Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosisQ61861985
Type IIa ('anti-Hu') antineuronal antibodies produce destruction of rat cerebellar granule neurons in vitroQ70514588
Demonstration of anti-HuD specific oligoclonal bands in the cerebrospinal fluid from patients with paraneoplastic neurological syndromes. Qualitative evidence of anti-HuD specific IgG-synthesis in the central nervous systemQ73153784
Intrathecal IgG synthesis and autoantibody-secreting cells in multiple sclerosisQ74016851
Neuronal apoptosis induced by cerebrospinal fluid from multiple sclerosis patients correlates with hypointense lesions on T1 magnetic resonance imagingQ77486551
Immunization with neurofilament light protein induces spastic paresis and axonal degeneration in Biozzi ABH miceQ80109125
Receptor revision and atypical mutational characteristics in clonally expanded B cells from the cerebrospinal fluid of recently diagnosed multiple sclerosis patientsQ81119751
P433issue5
P921main subjectmultiple sclerosisQ8277
relapsing-remitting multiple sclerosisQ18555066
P577publication date2015-09-01
P1433published inASN NeuroQ20312578
P1476titleA Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients
P478volume7

Reverse relations

cites work (P2860)
Q38657074Adaptive lymphocyte profiles correlate to brain Aβ burden in patients with mild cognitive impairment.
Q26770852B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation
Q104479846B cell depletion therapies in autoimmune disease: advances and mechanistic insights
Q30842875Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination
Q37645937Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patients
Q93062665Single-Cell High-Throughput Technologies in Cerebrospinal Fluid Research and Diagnostics

Search more.